Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS??? EQUITY (DEFICIT)

v3.22.2
CONDENSED STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common stocks
Treasury stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2020 73,690,340        
Beginning balance at Dec. 31, 2020 $ 86,997        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of preferred stock to redemption value $ 23,728        
Ending balance (in shares) at Mar. 31, 2021 73,690,340        
Ending balance at Mar. 31, 2021 $ 110,725        
Beginning balance (in shares) at Dec. 31, 2020   16,275,609      
Beginning balance (in shares) at Dec. 31, 2020     1,914,328    
Beginning balance at Dec. 31, 2020 (49,730) $ 2 $ (1,629) $ 10 $ (48,113)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of preferred stock to redemption value (23,728)     (586) (23,142)
Stock-based compensation 280     280  
Stock options exercised (in shares)   761,697      
Stock options exercised 306     306  
Net profit (loss) (1,936)       (1,936)
Ending balance (in shares) at Mar. 31, 2021   17,037,306      
Ending balance (in shares) at Mar. 31, 2021     1,914,328    
Ending balance at Mar. 31, 2021 $ (74,808) $ 2 $ (1,629) 10 (73,191)
Beginning balance (in shares) at Dec. 31, 2020 73,690,340        
Beginning balance at Dec. 31, 2020 $ 86,997        
Ending balance (in shares) at Jun. 30, 2021 73,690,340        
Ending balance at Jun. 30, 2021 $ 131,801        
Beginning balance (in shares) at Dec. 31, 2020   16,275,609      
Beginning balance (in shares) at Dec. 31, 2020     1,914,328    
Beginning balance at Dec. 31, 2020 (49,730) $ 2 $ (1,629) 10 (48,113)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net profit (loss) (3,595)        
Ending balance (in shares) at Jun. 30, 2021   18,319,305      
Ending balance (in shares) at Jun. 30, 2021     1,914,328    
Ending balance at Jun. 30, 2021 $ (96,042) $ 2 $ (1,629) 11 (94,426)
Beginning balance (in shares) at Mar. 31, 2021 73,690,340        
Beginning balance at Mar. 31, 2021 $ 110,725        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Accretion of preferred stock to redemption value $ 21,076        
Ending balance (in shares) at Jun. 30, 2021 73,690,340        
Ending balance at Jun. 30, 2021 $ 131,801        
Beginning balance (in shares) at Mar. 31, 2021   17,037,306      
Beginning balance (in shares) at Mar. 31, 2021     1,914,328    
Beginning balance at Mar. 31, 2021 (74,808) $ 2 $ (1,629) 10 (73,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accretion of preferred stock to redemption value (21,076)     (1,500) (19,576)
Stock-based compensation 1,440     1,440  
Stock options exercised (in shares)   1,281,999      
Stock options exercised 61     61  
Net profit (loss) (1,659)       (1,659)
Ending balance (in shares) at Jun. 30, 2021   18,319,305      
Ending balance (in shares) at Jun. 30, 2021     1,914,328    
Ending balance at Jun. 30, 2021 $ (96,042) $ 2 $ (1,629) 11 (94,426)
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 119,017,380 119,017,380      
Beginning balance (in shares) at Dec. 31, 2021     0    
Beginning balance at Dec. 31, 2021 $ 161,255 $ 12 $ 0 293,719 (132,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stocks and equity awards issued for acquisition of TVS (in shares)   11,549,465      
Common stock and equity awards issued for acquisition of TVS 47,152 $ 1   47,151  
Stock-based compensation 1,496     1,496  
Stock options exercised (in shares)   1,521,927      
Stock options exercised 462     462  
Net profit (loss) (7,449)       (7,449)
Ending balance (in shares) at Mar. 31, 2022   132,088,772      
Ending balance (in shares) at Mar. 31, 2022     0    
Ending balance at Mar. 31, 2022 $ 202,916 $ 13 $ 0 342,828 (139,925)
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 119,017,380 119,017,380      
Beginning balance (in shares) at Dec. 31, 2021     0    
Beginning balance at Dec. 31, 2021 $ 161,255 $ 12 $ 0 293,719 (132,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net profit (loss) $ (3,149)        
Ending balance (in shares) at Jun. 30, 2022 132,411,715 132,411,715      
Ending balance (in shares) at Jun. 30, 2022     0    
Ending balance at Jun. 30, 2022 $ 212,018 $ 13 $ 0 347,630 (135,625)
Beginning balance (in shares) at Mar. 31, 2022 0        
Beginning balance at Mar. 31, 2022 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Mar. 31, 2022   132,088,772      
Beginning balance (in shares) at Mar. 31, 2022     0    
Beginning balance at Mar. 31, 2022 202,916 $ 13 $ 0 342,828 (139,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 4,628     4,628  
Stock options exercised (in shares)   322,943      
Stock options exercised 174     174  
Net profit (loss) $ 4,300       4,300
Ending balance (in shares) at Jun. 30, 2022 132,411,715 132,411,715      
Ending balance (in shares) at Jun. 30, 2022     0    
Ending balance at Jun. 30, 2022 $ 212,018 $ 13 $ 0 $ 347,630 $ (135,625)